Cigna Reports Second Quarter 2016 Results, Solid Performance in Global Health Care Offset by Pressure in Group Disability and Life
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Leerink Partners Cuts Price Target on Cigna Corp. (CI) to $155 Following 2Q Miss
August 1, 2016 10:10 AM EDTLeerink Partners maintained an Outperform rating on CIGNA (NYSE: CI), and cut the price target to $155.00 (from $160.00), following the company's 2Q earnings report. The company reported an EPS miss of 39c and $1.20 guide-down driven mostly by Group Life & Disability but to a lesser extent Global Healthcare.
Analyst Ana Gupte commented, "We revise our CI 2017E and 2018E EPS to $9.50 & $10.88 after a surprise miss and guide-down on Disability & Life as well as a smaller miss in Healthcare. The miss in... More
Cigna Corp. (CI) Misses Q2 EPS Views; Updates FY16 EPS Outlook
July 29, 2016 6:01 AM EDTCigna Corp. (NYSE: CI) reported Q2 EPS of $1.98, $0.41 worse than the analyst estimate of $2.39. Revenue for the quarter came in at $9.89 billion versus the consensus estimate of $9.97 billion.
GUIDANCE:
Cigna Corp. sees FY2016 EPS of $7.75-$8.10, versus the consensus of... More
